- New energy-efficient EPYC Embedded 9004 Series combines embedded system-optimized features, enhanced security and scalability up to 96 cores —
- Siemens and Advantech are initial customers deploying solutions based on EPYC Embedded 9004 Series —
Revolution Medicines To Acquire EQRx In All-Stock Transaction To Gain Over $1B In Additional Capital
Revolution Medicines Inc (NASDAQ: RVMD) has agreed to acquire EQRx Inc (NASDAQ: EQRX) in an all-stock transaction intended to add more than $1 billion in net cash to